This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
HLA
2.73%
$1.88
HEALTHIA LIMITED - Announcements
Currently unlisted.
Proposed listing date: 11 SEPTEMBER 2018
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
HLA | HEALTHIA ANNOUNCES SETTLEMENT OF ACQUISITIONS | PRICE SENSITIVE | 21/03/19 | |
HLA | Half Yearly Report and Accounts | PRICE SENSITIVE | 21/02/19 | |
HLA | Chairman's Address to Shareholders | PRICE SENSITIVE | 28/11/18 | |
HLA | Healthia Announces Settlement of Acquisition | PRICE SENSITIVE | 23/11/18 | |
HLA | Acquisition of two physiotherapy clinics | PRICE SENSITIVE | 24/10/18 | |
HLA | Full Year Statutory Accounts | PRICE SENSITIVE | 26/09/18 | |
HLA HEALTHIA ANNOUNCES SETTLEMENT OF ACQUISITIONS | |||
21/03/19 | PRICE SENSITIVE | ||
HLA Half Yearly Report and Accounts | |||
21/02/19 | PRICE SENSITIVE | ||
HLA Chairman's Address to Shareholders | |||
28/11/18 | PRICE SENSITIVE | ||
HLA Healthia Announces Settlement of Acquisition | |||
23/11/18 | PRICE SENSITIVE | ||
HLA Acquisition of two physiotherapy clinics | |||
24/10/18 | PRICE SENSITIVE | ||
HLA Full Year Statutory Accounts | |||
26/09/18 | PRICE SENSITIVE | ||